New York, Feb 6, 2026, 14:30 EST — Regular session
- Confluent was trading close to $30.57 by the afternoon, a gain of roughly 0.7%.
- After lawsuits and shareholder pressure, the company has added more disclosures about its merger.
- Arbitrage spread remains tight, but with next week on the horizon, traders are watching for any signs of delays.
Confluent ticked up Friday—shares were up 0.7% at roughly $30.57 by 2:30 p.m. EST—after the company released fresh merger disclosures related to its pending IBM acquisition. The update followed increased investor pressure and two lawsuits aimed at the proxy. According to the latest filing, Confluent’s board faced 17 demand letters along with two legal actions in New York state court. The company said it will update its proxy materials before the Feb. 12 shareholder vote.
Why does this matter? Confluent shares hover just below IBM’s bid, creating a narrow deal spread. If legal snags or regulatory holdups emerge, that gap could widen fast. That’s the pocket where merger arbitrage funds hunt for returns—the sliver between current price and buyout offer.
IBM struck a deal in December to acquire Confluent for $31 a share in cash, putting an $11 billion price tag on the company. Both sides are aiming to wrap things up by mid-2026, pending approval from shareholders and regulators. Arvind Krishna, IBM’s chief executive, says the merger should let enterprises roll out generative and agentic AI “better and faster.” Confluent boss Jay Kreps, for his part, sees IBM’s global reach as a way to quicken Confluent’s game plan. IBM Newsroom
Shareholders receive a proxy statement packed with deal terms, background info, and the financials—designed to win over their votes. But once a transaction hits the ballot, lawsuits or demand letters frequently pop up, claiming the documents leave out important details.
Confluent left its main financials unchanged in the latest filing. Still, the company added more detail, aiming to reduce the risk of a surprise judicial intervention down the line.
The stock edged up on Friday, part of a rebound among U.S. tech shares following a rocky stretch for the sector. Chipmakers and software firms took the lead, as investors reconsidered the impact of heavy AI spending.
Earnings aren’t really the focal point for Confluent traders at the moment. It’s the timing that’s got their attention. Any update—maybe a court filing, a shift in shareholder demands, or a tweak to the expected closing date—could push the spread out versus that $31-per-share cash offer.
The risk? More lawsuits or drawn-out approvals could kill the deal, knocking the stock below the offer price. If things fall apart, Confluent’s shares would snap back to their baseline valuation—landing smack in a volatile sector.
Confluent will release its Q4 and full-year results on Feb. 11, right after the U.S. markets shut. That leaves just a short window before shareholders vote on the IBM buyout.
Related articles: NYSE:IBM
